2023-07-26 –, 32-124
Identified 4 Multiple Sclerosis drugs: Gilenya, Tysabri, Copaxone, and Tecfidera as the basis for conducting a manual textual analysis from feedback provided by patients at WebMD website. The objective was two fold: (1) complete a textual analysis, evaluating, on the dimensions of Ease of Use,
Effectiveness, and Satisfaction. After categorizing different feedback into various groups, these data were visualized and analyzed using Julia
Identified 4 Multiple Sclerosis drugs: Gilenya, Tysabri, Copaxone, and Tecfidera as the basis for conducting a manual textual analysis from feedback provided by patients at WebMD website. The objective was two fold: (1) complete a textual analysis, evaluating, on the dimensions of Ease of Use,
Effectiveness, and Satisfaction. After categorizing different feedback into various groups, these data were visualized and analyzed using Julia. Each brand had at least a minimum of 100 unique patients providing feedback - Tysabri had 222, Gilenya had 102, Tecfidera had 162 and Copaxone had 198. Analysis will include basic means comparisons using ANOVA based analysis in Julia
High School student with an interest in Pediatric Neurology, Public Health, and Medicine, starting college in Fall of 2023